Platinum Management Buys More Echo Therapeutics Inc (ECTE) Shares

Platinum Management, managed by Mark A. Nordlicht, has acquired 16,961 shares of Echo Therapeutics Inc (NASDAQ:ECTE), a new filing with the U.S. Securities and Exchange Commission showed. The shares were purchased in multiple transactions for a purchase price of $2.2 apiece. Currently, Platinum owns 1.61 million shares, up from 578,452 shares disclosed previously.

Echo Therapeutics Inc (ECTE)

In December 2013, Platinum Management reported upping its stake in Echo Therapeutics Inc (NASDAQ:ECTE) to 578,452 shares. Echo Therapeutics Inc (NASDAQ:ECTE) is a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system. The company has a market cap of $26.7 million.

Last week, Echo Therapeutics Inc. (NASDAQ: ECTE) announced that the company’s stockholders elected Shepard M. Goldberg as a new member of the company’s board of directors at the 2014 annual meeting of stockholders held June 19, 2014.

For the first quarter of 2014, the company reported net loss for of $2.8 million, or $0.23 per share, compared to $7.0 million, or $1.30 per share, for the first quarter of 2013. The operating loss for the quarter was $2.7 million compared to $5.5 million for the first quarter of 2013. Research and development expenses decreased by $2.1 million, or 64%, to $1.1 million for the first quarter, compared to $3.2 million for the first quarter of 2013, according to a statement.

On Wednesday, Echo Therapeutics Inc (NASDAQ:ECTE)’s stock gained 0.90% to $2.23. It has a 52 week high of $4.91 and a 52 week low of $1.53. The consensus average target price for the stock is $2.00, and the consensus average recommendation is ‘Hold.’

Other largest shareholders of Echo Therapeutics Inc (NASDAQ:ECTE) include Fred Knoll’s Knoll Capital Managementm, which holds 28,630 shares, Jim Simons’ Renaissance Technologies, which revealed ownership of 40,787 shares of the company.

Total value of Platinum Management’s equity portfolio totaled $211.71 million as of the end of the first quarter of 2014. In term of value, Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) was the largest holding, in which the fund owns 14.07 million shares. It is followed by NXP Semiconductors NV (NASDAQ:NXPI), in which the fund holds 168,000 shares.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!